Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.

van Rhee F, Rossi JF, Simpson D, Foss? A, Dispenzieri A, Kuruvilla J, Goh YT, Cho SG, Capra M, Liu T, Casper C, Cavet J, Wong RS. Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab. Br J Haematol. 2021 01; 192(1):e28-e31.

View in: PubMed

collapse authors with profiles